Revolution Medicines, Inc. (RVMD) — Analyst outlook / Analyst consensus target is. Based on 20 analyst ratings, the consensus is bullish — 1 Strong Buy, 18 Buy, 1 Hold.
The consensus price target is $124.36 (low: $73.00, high: $170.00), representing a downside of 15.4% from the current price $147.01.
Analysts estimate Earnings Per Share (EPS) of $-3.47 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-3.58 vs est $-3.47 (missed -3.1%). 2025: actual $-5.95 vs est $-5.65 (missed -5.4%). Analyst accuracy: 96%.
RVMD Stock — 12-Month Price Forecast
$124.36
▼ -15.41% Downside
Average Price Target
Based on 20 Wall Street analysts offering 12-month price targets for Revolution Medicines, Inc., the average price target is $124.36, with a high forecast of $170.00, and a low forecast of $73.00.
The average price target represents a -15.41% change from the last price of $147.01.
Highest Price Target
$170.00
Average Price Target
$124.36
Lowest Price Target
$73.00
RVMD Analyst Ratings
Buy
Based on 20 analysts giving stock ratings to Revolution Medicines, Inc. in the past 3 months
EPS Estimates — RVMD
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.58
vs Est –$3.47
▼ 3.0% off
2025
Actual –$5.95
vs Est –$5.65
▼ 5.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — RVMD
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
